Fibrosis — A Common Pathway to Organ Injury and Failure
- 2 July 2015
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 373 (1), 95-96
- https://doi.org/10.1056/nejmc1504848
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Fibrosis — A Common Pathway to Organ Injury and FailureNew England Journal of Medicine, 2015
- Rituximab for IgG4-related disease: a prospective, open-label trialAnnals Of The Rheumatic Diseases, 2015
- Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From OnsetGastroenterology, 2014
- Brief Report: Interleukin‐6 as an Inflammatory Mediator and Target of Therapy in Chronic PeriaortitisArthritis & Rheumatism, 2013
- Rituximab therapy for chronic periaortitisAnnals Of The Rheumatic Diseases, 2012
- Serotonin receptors and heart valve disease—It was meant 2BPharmacology & Therapeutics, 2011
- Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trialThe Lancet, 2011
- Drug-induced fibrotic valvular heart diseaseThe Lancet, 2009
- Drug-Induced Respiratory DisordersDrug Safety, 2000